We Can Learn More About an Embryo Than You Think

Many patients have no idea how important genetics are to reproductive decision making. There’s so much to know. We often refer to the concept of “genetics” as a big catchall bucket. But you really have to invest time into it… IVF is no longer as simple as putting an egg and sperm together.

If you are stepping into the world of in vitro fertilization (IVF), that sentiment might feel both overwhelming and incredibly validating. For decades, the cultural understanding of IVF was rudimentary: a laboratory intervention where an egg and sperm meet outside the body, resulting in a pregnancy.

But reproductive medicine has crossed a massive threshold. Today, we aren’t just creating embryos; we are reading more and more about their blueprints. If you want to exercise your right to make the best reproductive choices for yourself, you first need to educate yourself on what those choices are.

Beyond the “Catchall Bucket”

When families start their fertility journey, “genetics” is often tossed around as a vague buzzword. We blame genetics for our physical traits, our quirks, and our medical histories. But in the context of IVF, genetics is a highly specific, actionable map.

Through advancements like Preimplantation Genetic Testing (PGT), embryologists can screen embryos before they are ever transferred to the uterus. We can now look for:

• Aneuploidy (PGT-A): Ensuring the embryo has the correct number of chromosomes (46). An incorrect number is the leading cause of early miscarriage and implantation failure.

• Monogenic Disorders (PGT-M): Screening for specific inherited conditions—like Cystic Fibrosis, Huntington’s disease, or Sickle Cell Anemia—if the parents are known carriers.

• Structural Rearrangements (PGT-SR): Checking for chromosomal inversions or translocations that could lead to pregnancy loss or severe health issues.

• Polygenic Risk (PGT-P): An emerging screening that looks at the risk for complex, multi-gene conditions such as type 1 diabetes, heart disease, or certain cancers. It can also provide insights into specific non-medical traits (eye color, IQ). Rather than a definitive diagnosis, PGT-P provides a probability score, helping families select an embryo with the lowest risk for these illnesses, or prioritize embryos based on certain desired genetic characteristics.

We can learn more about a five-day-old cluster of cells today than we could learn about a full-term baby just a few decades ago.

The Power of Investing Your Time

Having this technology available can be seen as a miracle of modern science, but it can also place a new burden of choice on the parents. You have a whole bunch of options in front of you, and navigating them requires a genuine investment of your time and energy.

It requires sitting down with experts to map out your options. It means asking your reproductive endocrinologist hard questions about mosaic embryos, biopsy risks, and success rates. It involves understanding your own genetic carrier status before you even begin the retrieval process.

Yes, it is daunting. But knowledge is the ultimate anxiety-reducer. By investing the time to understand the genetics of your embryos, you transition from a passive patient hoping for the best into an active advocate for your future child’s health. While our passion at the IVF clinic is understandably about “getting a baby”, our top priority is getting a healthy baby. IVF is no longer just about creating life, it’s about giving that life the healthiest possible foundation.